data_1ttg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ttg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -54.7 100.52 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.88 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.66 30.94 6.98 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.339 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.72 121.85 20.29 Favored Pre-proline 0 N--CA 1.5 2.053 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -52.25 151.59 17.0 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 120.48 0.787 . . . . 0.0 111.259 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -153.08 -175.2 5.23 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.287 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 46.76 31.54 1.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.527 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.22 108.82 2.42 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.61 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -146.08 172.05 13.98 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.873 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.0 122.39 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.008 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.11 -42.95 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.719 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.94 168.61 25.31 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.307 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.08 115.27 8.84 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.489 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -95.46 161.83 26.52 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.078 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.21 4.43 0.24 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.187 1.258 . . . . 0.0 112.201 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.489 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.2 OUTLIER -160.76 21.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.646 -1.222 . . . . 0.0 111.953 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.407 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.9 OUTLIER -173.34 147.94 1.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.396 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.99 144.96 48.58 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.652 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tt -116.22 107.57 15.03 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.613 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 pt -97.98 159.19 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.466 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.17 121.44 7.27 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.239 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.533 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 14.5 p90 -122.84 -139.31 0.31 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.089 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 14.8 t70 -147.7 141.26 25.47 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.349 -1.34 . . . . 0.0 112.721 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.18 134.25 20.24 Favored Pre-proline 0 CA--C 1.561 1.4 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.244 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.04 -177.09 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 120.764 0.976 . . . . 0.0 111.957 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.49 -16.73 17.44 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.549 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 m -67.65 -179.68 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.829 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.57 97.26 5.0 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.094 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -93.82 112.52 26.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.105 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -59.5 -63.26 1.36 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.72 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -160.2 163.56 33.5 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.4 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -116.48 167.96 10.59 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.966 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -142.01 109.37 5.6 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.823 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mt -105.83 114.61 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.385 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.82 142.18 46.9 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.215 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.537 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 3.2 p90 -141.35 150.84 42.98 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 118.766 -1.174 . . . . 0.0 111.245 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -178.49 148.75 8.58 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 151.18 16.68 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.719 -0.793 . . . . 0.0 111.069 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.433 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 1.2 m -73.28 142.87 47.19 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.381 -0.927 . . . . 0.0 111.057 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.86 61.45 6.72 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.506 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.38 164.43 20.86 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -104.99 4.56 31.83 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.172 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.6 p -162.39 100.44 1.1 Allowed Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.908 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.32 147.35 95.1 Favored 'Trans proline' 0 C--O 1.217 -0.575 0 C-N-CA 120.589 0.86 . . . . 0.0 111.521 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.9 t -50.68 -76.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.277 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -171.62 -163.83 0.29 Allowed 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.558 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -170.74 164.15 8.0 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.424 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -157.01 158.98 37.53 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.21 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 p -113.32 164.57 13.4 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.626 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.618 ' C ' ' H ' ' A' ' 52' ' ' GLY . 17.6 m -153.17 152.84 28.65 Favored Pre-proline 0 C--N 1.304 -1.407 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.787 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.8 Cg_endo -58.48 13.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.105 1.203 . . . . 0.0 112.575 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.618 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 59.13 6.27 3.92 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.398 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -73.12 -32.13 64.74 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.902 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -97.41 137.45 36.37 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.104 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.1 m -93.84 0.17 56.09 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.466 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.9 p -136.13 161.81 34.67 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.352 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.23 144.1 9.34 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.624 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.9 m -95.16 147.71 23.16 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.958 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.4 tt -139.12 152.68 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.661 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.18 163.5 38.09 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.747 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.31 32.87 5.35 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.728 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.5 -157.45 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.581 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -150.47 142.35 15.5 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.436 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.51 160.7 46.74 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.07 1.18 . . . . 0.0 112.632 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.89 79.54 0.07 OUTLIER Glycine 0 N--CA 1.493 2.461 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.141 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 p -170.66 134.22 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 118.971 -1.092 . . . . 0.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -58.09 122.19 12.47 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.873 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -122.31 130.67 53.37 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.871 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.433 ' OG1' ' OG1' ' A' ' 39' ' ' THR . 3.8 m -112.21 119.66 39.11 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.576 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.59 144.22 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.634 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.3 m -135.43 132.09 37.02 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.188 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.8 m -118.36 126.1 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.418 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -104.04 104.85 14.86 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.418 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 85' ' ' SER . . . -84.54 94.61 8.61 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.897 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -96.56 108.68 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.078 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.8 p -94.39 -79.04 0.43 Allowed 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.65 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.37 155.69 4.34 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.728 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -119.63 -81.29 0.63 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.04 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.82 -12.73 0.38 Allowed Glycine 0 N--CA 1.504 3.208 0 C-N-CA 118.858 -1.639 . . . . 0.0 112.674 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.84 -80.56 0.11 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.414 -1.314 . . . . 0.0 112.335 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 t -49.5 111.52 2.06 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.201 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.3 Cg_exo -61.64 87.77 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 N-CA-C 110.427 -0.644 . . . . 0.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.06 80.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.006 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -59.29 102.94 0.15 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.147 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 3.7 m -58.52 -159.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.431 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -116.63 85.68 17.25 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.611 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -59.7 139.01 86.69 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 120.585 0.857 . . . . 0.0 110.249 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.3 tt -131.69 152.98 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.897 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.2 p -137.64 152.43 49.33 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.024 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.65 140.26 20.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.594 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -92.38 139.05 30.99 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.044 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -155.48 127.43 7.55 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.672 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.94 121.53 25.58 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.744 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.717 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -54.7 100.52 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.88 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.66 30.94 6.98 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.339 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.72 121.85 20.29 Favored Pre-proline 0 N--CA 1.5 2.053 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -52.25 151.59 17.0 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 120.48 0.787 . . . . 0.0 111.259 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -153.08 -175.2 5.23 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.287 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 46.76 31.54 1.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.527 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.22 108.82 2.42 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.61 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -146.08 172.05 13.98 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.873 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.0 122.39 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.008 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.11 -42.95 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.719 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.94 168.61 25.31 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.307 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.08 115.27 8.84 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -95.46 161.83 26.52 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.078 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.21 4.43 0.24 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.187 1.258 . . . . 0.0 112.201 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.2 OUTLIER -160.76 21.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.646 -1.222 . . . . 0.0 111.953 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -173.34 147.94 1.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.396 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.99 144.96 48.58 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.652 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tt -116.22 107.57 15.03 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.613 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 pt -97.98 159.19 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.466 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.17 121.44 7.27 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.239 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.533 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 14.5 p90 -122.84 -139.31 0.31 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.089 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 14.8 t70 -147.7 141.26 25.47 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.349 -1.34 . . . . 0.0 112.721 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.18 134.25 20.24 Favored Pre-proline 0 CA--C 1.561 1.4 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.244 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.04 -177.09 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 120.764 0.976 . . . . 0.0 111.957 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.49 -16.73 17.44 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.549 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.441 ' H ' HG13 ' A' ' 27' ' ' VAL . 1.3 m -67.65 -179.68 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.57 97.26 5.0 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.094 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -93.82 112.52 26.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.105 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -59.5 -63.26 1.36 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.72 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -160.2 163.56 33.5 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.4 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -116.48 167.96 10.59 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.966 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -142.01 109.37 5.6 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.823 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mt -105.83 114.61 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.385 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.82 142.18 46.9 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.215 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.811 ' CE1' HD11 ' A' ' 59' ' ' ILE . 3.2 p90 -141.35 150.84 42.98 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 118.766 -1.174 . . . . 0.0 111.245 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -178.49 148.75 8.58 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 151.18 16.68 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.719 -0.793 . . . . 0.0 111.069 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -73.28 142.87 47.19 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.381 -0.927 . . . . 0.0 111.057 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.86 61.45 6.72 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.506 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.38 164.43 20.86 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -104.99 4.56 31.83 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.172 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.6 p -162.39 100.44 1.1 Allowed Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.908 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.32 147.35 95.1 Favored 'Trans proline' 0 C--O 1.217 -0.575 0 C-N-CA 120.589 0.86 . . . . 0.0 111.521 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.9 t -50.68 -76.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.277 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -171.62 -163.83 0.29 Allowed 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.558 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -170.74 164.15 8.0 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.424 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -157.01 158.98 37.53 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.21 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 p -113.32 164.57 13.4 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.626 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 52' ' ' GLY . 17.6 m -153.17 152.84 28.65 Favored Pre-proline 0 C--N 1.304 -1.407 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.787 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.8 Cg_endo -58.48 13.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.105 1.203 . . . . 0.0 112.575 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 59.13 6.27 3.92 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.398 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -73.12 -32.13 64.74 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.902 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -97.41 137.45 36.37 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.104 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.1 m -93.84 0.17 56.09 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.466 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.9 p -136.13 161.81 34.67 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.352 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.23 144.1 9.34 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.624 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.9 m -95.16 147.71 23.16 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.958 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.811 HD11 ' CE1' ' A' ' 36' ' ' TYR . 11.4 tt -139.12 152.68 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.661 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.18 163.5 38.09 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.747 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.31 32.87 5.35 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.728 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.5 -157.45 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.581 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -150.47 142.35 15.5 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.436 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.51 160.7 46.74 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.07 1.18 . . . . 0.0 112.632 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.89 79.54 0.07 OUTLIER Glycine 0 N--CA 1.493 2.461 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.141 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 p -170.66 134.22 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 118.971 -1.092 . . . . 0.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -58.09 122.19 12.47 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.873 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -122.31 130.67 53.37 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.871 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.8 m -112.21 119.66 39.11 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.576 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.59 144.22 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.634 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.3 m -135.43 132.09 37.02 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.188 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 72' ' ' VAL . 32.8 m -118.36 126.1 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -104.04 104.85 14.86 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.418 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 85' ' ' SER . . . -84.54 94.61 8.61 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.897 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -96.56 108.68 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.078 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.8 p -94.39 -79.04 0.43 Allowed 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.65 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.37 155.69 4.34 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.728 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -119.63 -81.29 0.63 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.04 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.82 -12.73 0.38 Allowed Glycine 0 N--CA 1.504 3.208 0 C-N-CA 118.858 -1.639 . . . . 0.0 112.674 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.84 -80.56 0.11 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.414 -1.314 . . . . 0.0 112.335 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 t -49.5 111.52 2.06 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.201 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.3 Cg_exo -61.64 87.77 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 N-CA-C 110.427 -0.644 . . . . 0.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.06 80.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.006 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -59.29 102.94 0.15 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.147 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 3.7 m -58.52 -159.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.431 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -116.63 85.68 17.25 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.611 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -59.7 139.01 86.69 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 120.585 0.857 . . . . 0.0 110.249 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.3 tt -131.69 152.98 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.897 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.2 p -137.64 152.43 49.33 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.024 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.65 140.26 20.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.594 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -92.38 139.05 30.99 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.044 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -155.48 127.43 7.55 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.672 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.94 121.53 25.58 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.744 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.717 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -54.7 100.52 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.88 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.66 30.94 6.98 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.339 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.72 121.85 20.29 Favored Pre-proline 0 N--CA 1.5 2.053 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.917 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -52.25 151.59 17.0 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 120.48 0.787 . . . . 0.0 111.259 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -153.08 -175.2 5.23 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.287 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 46.76 31.54 1.47 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.527 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.22 108.82 2.42 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.61 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -146.08 172.05 13.98 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.125 -1.03 . . . . 0.0 111.873 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 t -103.0 122.39 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.008 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.11 -42.95 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.719 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.94 168.61 25.31 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.307 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.08 115.27 8.84 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -95.46 161.83 26.52 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.078 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.21 4.43 0.24 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.187 1.258 . . . . 0.0 112.201 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.2 OUTLIER -160.76 21.49 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.646 -1.222 . . . . 0.0 111.953 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -173.34 147.94 1.57 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.862 -1.135 . . . . 0.0 111.396 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.99 144.96 48.58 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.652 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tt -116.22 107.57 15.03 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.613 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 pt -97.98 159.19 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.466 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.17 121.44 7.27 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.239 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.533 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 14.5 p90 -122.84 -139.31 0.31 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.089 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 14.8 t70 -147.7 141.26 25.47 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.349 -1.34 . . . . 0.0 112.721 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.18 134.25 20.24 Favored Pre-proline 0 CA--C 1.561 1.4 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.244 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.04 -177.09 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 120.764 0.976 . . . . 0.0 111.957 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.49 -16.73 17.44 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.549 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.441 ' H ' HG13 ' A' ' 27' ' ' VAL . 1.3 m -67.65 -179.68 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 119.829 -0.749 . . . . 0.0 110.829 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.57 97.26 5.0 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.094 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 t -93.82 112.52 26.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.105 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -59.5 -63.26 1.36 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.72 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' N ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -160.2 163.56 33.5 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.684 -1.206 . . . . 0.0 112.4 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -116.48 167.96 10.59 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.966 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -142.01 109.37 5.6 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.823 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mt -105.83 114.61 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.385 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.82 142.18 46.9 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.215 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.811 ' CE1' HD11 ' A' ' 59' ' ' ILE . 3.2 p90 -141.35 150.84 42.98 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 118.766 -1.174 . . . . 0.0 111.245 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -178.49 148.75 8.58 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.049 -1.221 . . . . 0.0 110.049 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.35 151.18 16.68 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.719 -0.793 . . . . 0.0 111.069 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -73.28 142.87 47.19 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.381 -0.927 . . . . 0.0 111.057 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.86 61.45 6.72 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.506 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.38 164.43 20.86 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 119.908 -1.139 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -104.99 4.56 31.83 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.172 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 84.6 p -162.39 100.44 1.1 Allowed Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.908 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.32 147.35 95.1 Favored 'Trans proline' 0 C--O 1.217 -0.575 0 C-N-CA 120.589 0.86 . . . . 0.0 111.521 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.9 t -50.68 -76.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.277 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -171.62 -163.83 0.29 Allowed 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.558 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -170.74 164.15 8.0 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.424 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -157.01 158.98 37.53 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.21 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 p -113.32 164.57 13.4 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.626 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 52' ' ' GLY . 17.6 m -153.17 152.84 28.65 Favored Pre-proline 0 C--N 1.304 -1.407 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.787 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.8 Cg_endo -58.48 13.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.105 1.203 . . . . 0.0 112.575 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 59.13 6.27 3.92 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.292 -1.433 . . . . 0.0 110.398 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -73.12 -32.13 64.74 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.902 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -97.41 137.45 36.37 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.104 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.1 m -93.84 0.17 56.09 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.466 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.9 p -136.13 161.81 34.67 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.352 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.23 144.1 9.34 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.624 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.9 m -95.16 147.71 23.16 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.958 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.811 HD11 ' CE1' ' A' ' 36' ' ' TYR . 11.4 tt -139.12 152.68 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.661 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.18 163.5 38.09 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.747 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.31 32.87 5.35 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.728 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.5 -157.45 0.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.581 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -150.47 142.35 15.5 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.436 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.51 160.7 46.74 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.07 1.18 . . . . 0.0 112.632 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.89 79.54 0.07 OUTLIER Glycine 0 N--CA 1.493 2.461 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.141 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.2 p -170.66 134.22 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 118.971 -1.092 . . . . 0.0 111.345 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -58.09 122.19 12.47 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.873 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -122.31 130.67 53.37 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.871 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.8 m -112.21 119.66 39.11 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.576 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.59 144.22 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.634 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.3 m -135.43 132.09 37.02 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.188 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 72' ' ' VAL . 32.8 m -118.36 126.1 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.418 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -104.04 104.85 14.86 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.418 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 85' ' ' SER . . . -84.54 94.61 8.61 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.897 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.4 t -96.56 108.68 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.078 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.8 p -94.39 -79.04 0.43 Allowed 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.65 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.37 155.69 4.34 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.728 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.5 mtm180 -119.63 -81.29 0.63 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.04 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -142.82 -12.73 0.38 Allowed Glycine 0 N--CA 1.504 3.208 0 C-N-CA 118.858 -1.639 . . . . 0.0 112.674 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.84 -80.56 0.11 Allowed 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 118.414 -1.314 . . . . 0.0 112.335 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.9 t -49.5 111.52 2.06 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.201 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 84' ' ' SER . 4.3 Cg_exo -61.64 87.77 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 N-CA-C 110.427 -0.644 . . . . 0.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.06 80.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.006 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -59.29 102.94 0.15 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.147 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 3.7 m -58.52 -159.95 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.431 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -116.63 85.68 17.25 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.611 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -59.7 139.01 86.69 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 120.585 0.857 . . . . 0.0 110.249 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.3 tt -131.69 152.98 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.897 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.2 p -137.64 152.43 49.33 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.024 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.65 140.26 20.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.594 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -92.38 139.05 30.99 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.044 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -155.48 127.43 7.55 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.672 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.94 121.53 25.58 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.744 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 116.286 -1.816 . . . . 0.0 110.717 -179.901 . . . . . . . . 1 1 . 1 stop_ save_